3M Warned On Sales Materials For Maxair Autohaler
This article was originally published in The Pink Sheet Daily
Executive Summary
DDMAC warning letter issued as company nears sale of its pharmaceutical business.
You may also be interested in...
Newcomer Graceway Acquires 3M’s American Pharmaceutical Business
Headed by former King chief Gregory, the nine-month-old Tennessee pharma gains access to 3M’s immune response modifier platform on which to build a portfolio.
Newcomer Graceway Acquires 3M’s American Pharmaceutical Business
Headed by former King chief Gregory, the nine-month-old Tennessee pharma gains access to 3M’s immune response modifier platform on which to build a portfolio.
FDA Warning Letter Targets Ligand Oncologics
DDMAC letter coincides with completion of Eisai’s acquisition of Ligand’s Ontak and Targretin.